“Safety and Tolerability of Bruton’s Tyrosine Kinase Inhibitors in the Treatment of Waldenström Macroglobulinemia”. Canadian Hematology Today, vol. 1, no. S06, June 2022, https://doi.org/10.58931/cht.2022.1S0628.